An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
The Ted Rogers Centre is proud to announce the launch of a unique new program: Entrepreneurship for Cardiovascular Health Opportunities (ECHO).
ECHO is a specialized hands-on training program led by veteran entrepreneurs and consultants across a variety of sectors. ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities.
For more information and to apply, visit https://tedrogersresearch.ca/echo.